Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Recordati Enters into Collaboration with Moderna to Advance mRNA Therapy for Propionic Acidemia

Friday, January 30, 2026

Recordati has announced a strategic collaboration and licence agreement with Moderna to develop and commercialise mRNA globally for the treatment of propionic acidemia a rare inherited metabolic disorder

Japan Approves 330 Billion JPY Support Package to Boost Drug Discovery and Biopharma Sector

Thursday, January 29, 2026

Japans Cabinet Office approves billion JPY package targeting bioclusters rare disease trials cellgene therapy and biosimilars to strengthen its biopharma infrastructure

WuXi Biologics Enters into Partnership with Sinorda Biomedicine for Bispecific Antibody Development

Thursday, January 29, 2026

WuXi Biologics and Sinorda Biomedicine have entered into a strategic collaboration to support the development and manufacturing of SND an innovative bispecific antibody being developed for inflammatory bowel disease and other autoimmune conditions

Immix Biopharma Receives FDA Breakthrough Therapy Designation for NXC-201 for AL Amyloidosis

Thursday, January 29, 2026

Immix Biopharma has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to NXC for the treatment of relapsed or refractory AL amyloidosis

Insilico Medicine Enters into Collaboration with Qilu Pharmaceutical to Advance Cardiometabolic Drug Development

Wednesday, January 28, 2026

Insilico Medicine and Qilu Pharmaceutical Group along with its subsidiary Shanghai Qilu Pharmaceutical Research Center have entered into a strategic partnership to develop new treatments for cardiometabolic diseases

Boehringer Ingelheim and Simcere Partner to Develop Dual-target Antibody for Inflammatory Bowel Disease

Wednesday, January 28, 2026

Boehringer Ingelheim and Simcere Pharmaceutical Group have entered into a licensing and collaboration agreement to develop SIM a preclinical bispecific antibody for the treatment of inflammatory bowel disease IBD

Nuance Pharma Announces NMPA Acceptance of NDA for Ohtuvayre (Ensifentrine) for COPD Maintenance Treatment in China

Tuesday, January 27, 2026

Nuance Pharmas New Drug Application for Ohtuvayre ensifentrine has been accepted for review by Chinas National Medical Products Administration for chronic obstructive pulmonary disease maintenance treatment

WuXi Biologics Enters into Partnership with HanchorBio to Develop Next-Generation Fusion Proteins

Tuesday, January 27, 2026

WuXi Biologics has entered a strategic collaboration with HanchorBio The partnership aims to advance multiple bi and multifunctional fusion protein programmes from HanchorBios pipeline

China-ASEAN Regional Medical Products Trading Platform Concludes First 2026 Transaction Boosting Pharma Exports

Monday, January 26, 2026

The ChinaASEAN Regional Medical Products Trading Platform finalized its first deal worth over million yuan between Qilu Pharmaceutical and a Thai buyer enhancing regional pharma trade

Janux Therapeutics Enters into Collaboration with Bristol Myers Squibb to Advance Tumour-Activated Cancer Therapy

Friday, January 23, 2026

Janux Therapeutics has entered into a collaboration and exclusive worldwide licensing agreement with Bristol Myers Squibb to develop a new tumouractivated therapy for solid tumours The partnership will focus on an undisclosed therapeutic candidate th...